Clinical Trials Logo

Clinical Trial Summary

Prolonged air leak, defined as air leak present 5 days after lung resection, is one of the most common complications after lung resection. This leads to patient discomfort (as the chest tube has to stay in place while air leak is present), prolonged stay, and increased cost.

NeoVeil is a bioabsorbable glycolic acid which has been used in Japan and other Asian countries for air leak prevention after lung resections. NeoVeil is impregnated with fibrin sealant materials and is placed on the lung surface at the time of operation. It then acts as a scaffold on resected area which is prone to air leak.

This randomized clinical trial will be the first in the United States to test its efficacy for air leak prevention.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04317924
Study type Interventional
Source Boston Medical Center
Contact
Status Withdrawn
Phase N/A
Start date October 2020
Completion date June 2022

See also
  Status Clinical Trial Phase
Completed NCT03021369 - Comparison of Two Different Pleural Drainage Systems N/A
Recruiting NCT05854654 - Air Leak Detection and Treatment N/A
Not yet recruiting NCT06293885 - Pleurodesis Using Hypertonic Glucose Phase 2
Completed NCT03450265 - Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection N/A
Completed NCT03056716 - Silastic Versus Conventional Drain in Thoracic Surgery N/A
Recruiting NCT05971719 - Validation of a System Using Aerosol Glycerine to Detect and Localize Intraoperatively Pulmonary Air Leaks N/A